The global gastrointestinal rare diseases treatment market was worth US$ 1,314.8 million in 2022 and is expected to be worth US$ 1,965 million by 2032, growing at a CAGR of 3.7% during the forecast period. The increasing awareness of gastrointestinal diseases and the development of various medications can be attributed to the growth of the …